PanTera
Focuses on producing actinium-225, a rare radioisotope used in targeted alpha therapies for cancer.
About
PanTera is a Belgian company focused on the large-scale, reliable production of Actinium-225 (Ac-225), a scarce radioisotope critical for emerging targeted alpha therapies in cancer treatment. They are constructing a state-of-the-art production facility in Mol, Belgium, utilizing a proprietary process to transform Radium-226 into high-purity Ac-225.
Technology stack
detected 2026-06-11Est. monthly stack spend~$770/mo
Email
Microsoft 365
Hosting
self_managed
Stack
Tailwind CSS
WordPress
SEO
Yoast SEO
Compliance
GDPR
CCPA
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does PanTera do?
PanTera is a Belgian company focused on the large-scale, reliable production of Actinium-225 (Ac-225), a scarce radioisotope critical for emerging targeted alpha therapies in cancer treatment. They are constructing a state-of-the-art production facility in Mol, Belgium, utilizing a proprietary process to transform Radium-226 into high-purity Ac-225.
How much funding has PanTera raised?
PanTera has raised a total of $122M in funding. The most recent round on record is Series A.
Where is PanTera headquartered?
PanTera is headquartered in Mol, Belgium.
When was PanTera founded?
PanTera was founded in 2022.
How many employees does PanTera have?
PanTera has approximately 58 people on record.